主要肺动脉肉瘤的临床特征:系统性审查和聚合分析
Fumihiro Kashizaki1, Hao Chen1, Nanami Tsuchiya1
1Department of Respiratory Medicine, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
Archivos de bronconeumologia
|January 18, 2025
概括
初级肺动脉肉瘤 (PPAS) 是罕见的,但像18F-FDG PET/CT这样的先进成像技术有助于诊断. 完整的手术切除显著改善了PPAS患者的整体存活率 (OS).
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 心血管外科心血管外科
背景情况:
- 初级肺动脉肉瘤 (PPAS) 是一种罕见的恶性瘤,通常具有非特异性的临床表现.
- 诊断方面的挑战仍然存在,可能会影响患者的治疗结果和治疗策略.
- 医学成像技术的最新进展可能为PPAS提供了更好的诊断能力.
研究的目的:
- 进行关于初级肺动脉肉瘤 (PPAS) 的病例报告和系列的综合分析.
- 在先进的医学成像时代,分析PPAS患者的临床特征和整体生存期 (OS).
- 评估现代成像方法在区分PPAS与肺血栓塞栓症 (PTE) 等其他疾病中的作用.
主要方法:
- 在PubMed和CINAHL进行了全面的文献搜索,搜索了2014年1月1日至2023年12月31日期间发表的研究.
- 数据提取包括患者人口统计学,诊断结果,治疗方法和确认PPAS病例的生存结果.
- 进行了聚合分析,以评估临床特征和整体生存 (OS) 趋势.
主要成果:
- 分析了643名PPAS患者;最初误诊为肺血栓塞栓症 (PTE) 是常见的 (70.6%).
- 使用2-deoxy-2-18F-fluoro-d-glucose (18F-FDG PET/CT) 的计算机断层扫描 (CT) 集成正子发射断层扫描在93.9%的病例中显示出有意义的发现.
- 手术 (81.4%) 和化疗 (66.4%) 是常见的治疗方法,完整的手术切除和晚期化疗与改善的整体存活率 (OS) 相相关 (中位数OS:31个月).
结论:
- 先进的成像,特别是18F-FDG PET/CT和多检测器行CT,可以有效地区分PPAS和PTE.
- 这些成像技术似乎有助于更早的诊断,并可能改善PPAS患者的整体存活率 (OS).
- 在被诊断为PPAS的个体中,完全切除手术是实现更长的整体存活 (OS) 的关键因素.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


